(Liz Highleyman/ Cancer Health) — Most cancer patients with solid tumors had good antibody responses after receiving COVID-19 vaccines, but the response rate was lower for those with blood cancers, such as leukemia or lymphoma, according to study findings published in Cancer Cell.
People with severe immune suppression, including cancer patients who use immune-suppressing therapy and transplant recipients who take immunosuppressive drugs to prevent organ rejection, are at risk for more severe complications and death due to COVID-19. They can also have slower and weaker immune responses after natural infection or vaccination. (…)
[button href=”https://www.cancerhealth.com/article/people-cancer-respond-covid19-vaccines” arrow=”true” new_tab=”true”]read full story[/button]: